Keywords: Prostate; Cancer; Biomarkers; Screening; PSA;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ACN; acetonitrile; CCD; central composite design; ESI; electrospray ionization; FA; formic acid; LOQ; limit of quantification; ME; Matrix effect; MeOH; methanol; MRL; maximum residue limit; MRM; multiple-reaction-monitoring; PSA; primary secondary amine;
Keywords: CDK; cyclin-dependent kinase; PTMs; post-translational modifications; AR; androgen receptor; PCa; prostate cancer; PSA; prostate specific antigen; ENZ; enzalutamide; CSS; charcoal stripped serum; FBS; fetal bovine serum; ER; estrogen receptor; PR; progest
Keywords: Influenza; Cost-effectiveness; Vaccination; Trivalent; Quadrivalent; Dynamic transmission model; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; HIV; human immunodeficiency virus; IBS; individual based simulation; I$; internationa
Keywords: Solar thermal electricity; Methane decomposition; Direct carbon fuel cells; Hydrogen fuel cells; AFC; Alkaline fuel cell; CSP; Concentrated solar power; DCFC; Direct carbon fuel cell; FC; Fuel cell; HFC; Hydrogen fuel cell; MCFC; Molten carbonates fuel ce
Keywords: Immobilized artificial membrane; Time-of-flight mass spectrometry; Blood-brain barrier; Quantitative structure-activity relationship; Liquid chromatography; High-throughput; AA; ammonium acetate; APC; Amemiya predictive criterion; BBB; blood-brain barrier
Keywords: Comet; Long term archive; International mission; PSA; PDS; Rosetta;
Keywords: IGZO; Indium gallium ZnO; CMOS; Complementary metal-oxide semiconductor; PAC; Polymer-like amorphous carbon; AFP; Anti-α-feptoprotein; PSA; Prostate specific antigen; cTnT; Cardiac troponin T; CEA; Carcinoembryonic antigen; PNA; Peptide nucleic acid; APT
Keywords: Polar drugs; Diffusion; Hydrophobic thickness; Area modulus; Polar surface area; ASA; acetylsalicylic acid; Calcein; 3,3-bis[N,N-bis(carboxymethyl)-aminomethyl]fluorescein; CMC; critical micellization concentration; CSâ1; compressibility modulus; CW STE
Keywords: prostatic neoplasms; mass screening; mortality; failure to rescue; health care; early detection of cancer; DRE; digital rectal examination; ERSPC; European Randomized study of Screening for Prostate Cancer; PSA; prostate specific antigen; TRUS; transrecta
Keywords: Prostate; Prostate cancer; Prostate cancer screening; Prostate cancer screening guidelines; Prostate-specific antigen; PSA; History of prostate cancer screening; United States Preventive services Task Force;
Keywords: AP-1; activated protein-1; COX; cyclooxygenase; CRP; C reactive protein; DNA; deoxy-ribonucleic acid; EGF; epidermal growth factor; ery; erythrocyte; HbA1c; glycated haemoglobin; HCHO; formaldehyde; HIF-1; hypoxia induced factor; IFNG; interferon-gamma;
Keywords: AE; adverse event; AS; ankylosing spondylitis; BCVA; best-corrected visual acuity; EL; evidence level; ISC; International Steering Committee; NCSIT; noncorticosteroid systemic immunomodulatory therapy; NIU; noninfectious uveitis; PsA; psoriatic arthritis;
Keywords: Ab; antibody; Ab*; labeled antibody; ACE; affinity capillary electrophoresis; AFP; alpha-fetoprotein; Ag; antigen; ALP; alkaline phosphatase; AuNPs; gold nanoparticles; AuNRs; functionalized gold nanorods; BA MNPs; boronate affinity magnetic nanoparticles
Keywords: 4- Shogaol (PubChem CID: 9794897); 6- Shogaol (PubChem CID: 5281794); Apigenin (PubChem CID: 5280443); Berberine (PubChem CID: 2353); Bergamottin (PubChem CID: 5471349); Caffeic acid (PubChem CID: 689043)Capsaicin (PubChem CID: 1548943); Cardamonin (PubCh
Keywords: Emerging persistent organic pollutants; Perfluoroalkyl substances; Novel brominated flame retardants; Organophosphorus flame retardants; Aquatic ecosystem; Sample treatment; Extraction; Analytical determination; μSIS; micro-selected ion storage mode; 1-M
Keywords: prostatic neoplasms; prostate-specific antigen; prostatectomy; neoplasm recurrence; local; early detection of cancer; BCR; biochemical recurrence; CSS; cancer specific survival; MFS; metastasis-free survival; PSA; prostate specific antigen; RP; radical pr
Keywords: AA; ascorbic acid; ABTS; 2,2â²-azino-bis(3-ethylbenzthiazoline-6-sulfonicacid) diammonium salt; AEF; analytical enhancement factor; AFP; alpha fetoprotein; Anti-CEA; anticarcinoembryonic antibody; Au NBPs; gold nanobipyramids; AuNCs; gold nanoclusters; A
Keywords: 3-BC; 3-Benzylidene camphor; 3,4 DHB; 3,4-Dihydroxybenzoic acid; 4-HB; 4-Hydroxybenzoic acid; 4-MBC; 4-Methylbenzylidene camphor; ABDI; Celestolide, 1-[6-(1,1-Dimethylethyl)-2,3-dihydro-1,1-dimethyl-1H-inden-4-yl]-ethanone; ACN; Acetonitrile; AHMI; Phanto
Keywords: prostatic neoplasms; guidelines as topic; prostate-specific antigen; advisory committees; AUA; American Urological Association; ERSPC; European Randomized Study of Screening for Prostate Cancer; PCa; prostate cancer; PLCO; Prostate, Lung, Colorectal and O
Keywords: prostatic neoplasms; prostate-specific antigen; brachytherapy; androgen antagonists; disease-free survival; ADT; androgen deprivation therapy; bDFS; biochemical disease-free survival; BF; biochemical failure; EBRT; external beam radiotherapy; LDR-BT; low
Keywords: Urolithins; Prostate cancer; Interactions; Ellagitannins gut metabolites; ADT; androgen deprivation therapy; AR; androgen receptor; bic; bicalutamide; CI; combination index; DHT; dihydrotestosterone; GnRH; gonadotropin-releasing hormone; PSA; prostate spe
Keywords: prostatic neoplasms; prostatectomy; watchful waiting; mass screening; disease progression; AS; active surveillance; EPE; extraprostatic extension; GS; Gleason score; MRI; magnetic resonance imaging; PC; prostate cancer; PSA; prostate specific antigen; RP;
Keywords: prostatic neoplasms; neoplasm recurrence; local; ultrasound; high-intensity focused; transrectal; postoperative complications; salvage therapy; ADT; androgen deprivation therapy; AE; adverse event; CaP; prostate cancer; EBRT; external beam radiation thera
Keywords: aHR; adjusted hazard ratio; BMI; body mass index; CI; confidence interval; GP; general practitioner; HR; hazard ratio; iHOPE; Incident Health Outcomes and Psoriasis Event; NAFLD; nonalcoholic fatty liver disease; PsA; psoriatic arthritis; PsO; psoriasis;
Keywords: AYL; type AY from Candida cylindracea; BDO; 1,4-butanediol; [C4mim][BF4]; 1-butyl-3-methylimidazolium tetrafluoroborate; [C4mim][NTf2]; 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)amide; [C4mim][PF6]; 1-butyl-3-methylimidazolium hexafluorophos
Keywords: prostatic neoplasms; prostatectomy; high-intensity focused ultrasound ablation; cryotherapy; robotic surgical procedures; ADT; androgen deprivation therapy; BCR; biochemical recurrence; EBRT; external beam radiotherapy; HIFU; high intensity focused ultras
Keywords: AgNP; silver nanoparticle; AIE; aggregation-induced emission; ATRP; atom transfer radical polymerization; AuNP; gold nanoparticle; CAC; critical aggregation concentration; CEVE; 2-chloroethyl vinyl ether; CFU; colony forming units; CLSI; Clinical and Labo
Keywords: prostatic neoplasms; prostatectomy; elasticity imaging techniques; diagnostic imaging; pathology; DRE; digital rectal examination; GS; Gleason score; LRP; laparoscopic radical prostatectomy; MRI; magnetic resonance imaging; PCa; prostate cancer; PSA; pros
Keywords: prostatic neoplasms; castration-resistant; subcutaneous fat; prognosis; tomography; x-ray computed; mortality; ADT; androgen deprivation therapy; ARAT; androgen receptor axis targeted; BMI; body mass index; CCI; Charlson Comorbidity Index; CRPC; castratio
Keywords: prostatic neoplasms; prostate-specific antigen; data accuracy; mortality; United States Department of Veterans Affairs; EHR; electronic health record; NCDB; National Cancer Database; PSA; prostate specific antigen; SEER; Surveillance, Epidemiology and End
Keywords: ARSIs; androgen receptor signaling inhibitors; AA; abiraterone acetate; AR; androgen receptor; BPH; benign prostatic hyperplasia; CNV; copy number variation; CRPC; castration resistant prostate cancer; CTC; circulating tumor cells; ctDNA; cell-free circul
Keywords: biopsy; internship and residency; ultrasound; high-intensity focused; transrectal; neoplasm grading; prostatic neoplasms; PGY; postgraduate year; PSA; prostate specific antigen; RP; radical prostatectomy; TRUS; transrectal ultrasound;
Keywords: ATR; Autothermal reforming; BCFZ; Perovskite membrane type with composition of BaCo0.4Fe0.4Zr0.2O3âδ; FBR; Fluidized bed reactor without membrane; FBMR; Fluidized bed membrane reactor; PMAFBR; Perovskite membrane-assisted fluidized bed reactor; MIEC; M
Keywords: ADT; androgen deprivation therapy; AE; adverse event; CRPC; castration-resistant prostate cancer; LHRH; luteinizing hormone-releasing hormone; mCRPC; metastatic CRPC; MFS; metastase-free survival; nmCRPC; non-metastatic CRPC; PFS; progression-free surviva
Keywords: Hepatocellular carcinoma; Overall survival; Disease-free survival; Outcome; Anatomic resection; Parenchyma-sparing; HCC; Hepatocellular carcinoma; AR; Anatomic resection; PSR; Parenchyma-sparing resection; PSA; Propensity score analysis; DFS; Disease-free
Keywords: Deep brain stimulation; Essential tremor; Pulse width; Therapeutic window; VIM; PSA;
Keywords: Hydrogen; Biomass; Gasification; Bangladesh; Renewable fuel; PSA;
Keywords: AAV; ANCA-associated vasculitis; ACPA; anti-citrullinated protein antibodies; AID; autoimmune disease; AIM; autoimmune myopathies; AInfD; autoinflammatory disease; AS; ankylosing spondylitis; DZ; dizygotic; ER; endoplasmic reticulum; FMF; familial Mediter
Keywords: prostatic neoplasms; biopsy; magnetic resonance imaging; genomics; pathology; ADC; apparent diffusion coefficient; AP; adverse pathology; GPSâ¢; Genomic Prostate Score; GS; Gleason score; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; NCCN;
Keywords: ADHD; Attention-deficit/hyperactivity disorder; ANOVA; Analysis of variance; PBS; Phosphate buffered saline; PIB; Polyisobutylene; PSA; Pressure sensitive adhesives; RP-HPLC; Reverse phase high performance liquid chromatography; SE; Standard error; TDDS;
Keywords: prostatic neoplasms; castration-resistant; surveys and questionnaires; case reports; practice patterns; physicians; ADT; androgen deprivation therapy; CME; continuing medical education; CT; computerized tomography; LHRH; luteinizing hormone-releasing horm
Keywords: prostatic neoplasms; urinary tract; microbiota; inflammation; bacteria; BPH; benign prostatic hyperplasia; ISUP; International Society of Urological Pathology; OTU; operational taxonomic unit; PCR; polymerase chain reaction; PSA; prostate specific antigen
Keywords: 5α-adiol; 5α-androstan-3α,17β-diol; 5β-adiol; 5β-androstan-3α,17β-diol; A; androsterone; ANOVA; analysis of variance; AUC; area under the curve; CV%; coefficient of variation; CV; cross validation; DA; discriminant analysis; DHEA; dehydroepiandros
Keywords: AM; Acrylamide; APTES; 3-Aminopropyltriethoxysilane; ATRP; Atom transfer radical polymerization; BHb; Bovine hemoglobin; BSA; Bovine serum albumin; CLRP; Controlled/living radical polymerization; CTAB; Cetyltrimethylammonium bromide; cTnT; Cardiac troponi
Keywords: prostatic neoplasms; decision making; patient participation; patient reported outcome measures; quality of life; AS; active surveillance; DCS; decision conflict scale; HRQoL; health related quality of life; PC; prostate cancer; PSA; prostate specific anti
Keywords: coronary artery bypass grafting; operative mortality; perioperative beta-blocker use; AF; atrial fibrillation; CABG; coronary artery bypass grafting; CI; confidence interval; MI; myocardial infarction; OR; odds ratio; PSA; propensity score analysis; RA; r
Keywords: AA; atrial arrhythmia; AC; alternating current; AF; atrial fibrillation; AHRE; atrial high rate event; AMS; automatic mode switch; ASCVD; atherosclerotic cardiovascular disease; AT; atrial tachyarrthymia; AUC; area under the curve; BMI; body mass index; B
Keywords: 4 years; interleukin 17; ixekizumab; long-term; open-label; psoriasis; BCC; basal cell carcinoma; DLQI; Dermatology Life Quality Index; HADS; Hospital Anxiety and Depression Scale; IBD; inflammatory bowel disease; IL; interleukin; LOCF; last observation c
Keywords: LSPR; localized surface plasmon resonance; POCT; point-of-care testing; AuNPs; gold nanoparticles; AuNRs; gold nanorods; AgNPs; silver nanoparticles; AgNPRs; silver nanoprisms; Ag@AuNPs; silver-coated gold nanoparticles; Ag@AuNRs; silver-coated gold nanor